You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

You’ve been redirected to the new Cancer Care Ontario website. You can also visit the archived website, which is no longer being maintained.

Chemotherapy with Radiotherapy for Nasopharyngeal Cancer

Version: 2 ID: 5-7 May 2013
Type of Content: Guidelines & Advice, Clinical
Document Status: In-Review
Authors:
K. Thephamongkhol, G. Browman, I. Hodson, T. Oliver, L. Zuraw, Head Neck Cancer Disease Site Group

Patient Population

Adult patients with newly diagnosed locally advanced squamous cell or undifferentiated nasopharyngeal cancer (stage III or IV) who are being considered for radiotherapy as the definitive modality for curative intent and who can tolerate chemotherapy, in the judgement of the treating oncologist.

Research Question(s)

Does the addition of chemotherapy to radiotherapy improve the survival of adult patients with newly diagnosed locally advanced squamous cell or undifferentiated nasopharyngeal cancer? If so, what is the best timing and regimen of chemotherapy?

pdf download Summary (PDF) (270.73 KB)